373 related articles for article (PubMed ID: 17942543)
21. Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
Devaiah BN; Singer DS
J Biol Chem; 2012 Nov; 287(46):38755-66. PubMed ID: 23027873
[TBL] [Abstract][Full Text] [Related]
22. Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II.
Larochelle S; Amat R; Glover-Cutter K; Sansó M; Zhang C; Allen JJ; Shokat KM; Bentley DL; Fisher RP
Nat Struct Mol Biol; 2012 Nov; 19(11):1108-15. PubMed ID: 23064645
[TBL] [Abstract][Full Text] [Related]
23. The Interactive Complex between Cytomegalovirus Kinase vCDK/pUL97 and Host Factors CDK7-Cyclin H Determines Individual Patterns of Transcription in Infected Cells.
Schütz M; Cordsmeier A; Wangen C; Horn AHC; Wyler E; Ensser A; Sticht H; Marschall M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139252
[TBL] [Abstract][Full Text] [Related]
24. The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription.
Hoque M; Young TM; Lee CG; Serrero G; Mathews MB; Pe'ery T
Mol Cell Biol; 2003 Mar; 23(5):1688-702. PubMed ID: 12588988
[TBL] [Abstract][Full Text] [Related]
25. Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development.
Caracciolo V; Laurenti G; Romano G; Carnevale V; Cimini AM; Crozier-Fitzgerald C; Gentile Warschauer E; Russo G; Giordano A
Cell Cycle; 2012 Mar; 11(6):1202-16. PubMed ID: 22391209
[TBL] [Abstract][Full Text] [Related]
26. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
[TBL] [Abstract][Full Text] [Related]
27. Replication-dependent DNA damage response triggered by roscovitine induces an uncoupling of DNA replication proteins.
Savio M; Cerri M; Cazzalini O; Perucca P; Stivala LA; Pichierri P; Franchitto A; Meijer L; Prosperi E
Cell Cycle; 2006 Sep; 5(18):2153-9. PubMed ID: 16969115
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo.
Majello B; Napolitano G; Giordano A; Lania L
Oncogene; 1999 Aug; 18(32):4598-605. PubMed ID: 10467404
[TBL] [Abstract][Full Text] [Related]
29. The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0.
Davido DJ; Leib DA; Schaffer PA
J Virol; 2002 Feb; 76(3):1077-88. PubMed ID: 11773384
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.
Chen R; Wierda WG; Chubb S; Hawtin RE; Fox JA; Keating MJ; Gandhi V; Plunkett W
Blood; 2009 May; 113(19):4637-45. PubMed ID: 19234140
[TBL] [Abstract][Full Text] [Related]
31. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Whittaker SR; Walton MI; Garrett MD; Workman P
Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
[TBL] [Abstract][Full Text] [Related]
32. Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors.
Diwan P; Lacasse JJ; Schang LM
J Virol; 2004 Sep; 78(17):9352-65. PubMed ID: 15308730
[TBL] [Abstract][Full Text] [Related]
33. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
Isel C; Karn J
J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
[TBL] [Abstract][Full Text] [Related]
34. Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure.
Sano M; Wang SC; Shirai M; Scaglia F; Xie M; Sakai S; Tanaka T; Kulkarni PA; Barger PM; Youker KA; Taffet GE; Hamamori Y; Michael LH; Craigen WJ; Schneider MD
EMBO J; 2004 Sep; 23(17):3559-69. PubMed ID: 15297879
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug Combinations.
Wild M; Hahn F; Brückner N; Schütz M; Wangen C; Wagner S; Sommerer M; Strobl S; Marschall M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269635
[TBL] [Abstract][Full Text] [Related]
36. Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells.
Darbinian N; Sawaya BE; Khalili K; Jaffe N; Wortman B; Giordano A; Amini S
J Neuroimmunol; 2001 Dec; 121(1-2):3-11. PubMed ID: 11730934
[TBL] [Abstract][Full Text] [Related]
37. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.
Schang LM; Rosenberg A; Schaffer PA
J Virol; 1999 Mar; 73(3):2161-72. PubMed ID: 9971799
[TBL] [Abstract][Full Text] [Related]
38. Cyclins that don't cycle--cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size.
Sano M; Schneider MD
Cell Cycle; 2003; 2(2):99-104. PubMed ID: 12695656
[TBL] [Abstract][Full Text] [Related]
39. Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy.
Sano M; Abdellatif M; Oh H; Xie M; Bagella L; Giordano A; Michael LH; DeMayo FJ; Schneider MD
Nat Med; 2002 Nov; 8(11):1310-7. PubMed ID: 12368904
[TBL] [Abstract][Full Text] [Related]
40. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.
Kiernan RE; Emiliani S; Nakayama K; Castro A; Labbé JC; Lorca T; Nakayama Ki K; Benkirane M
Mol Cell Biol; 2001 Dec; 21(23):7956-70. PubMed ID: 11689688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
